770
Views
10
CrossRef citations to date
0
Altmetric
Review

Pediatric irritable bowel syndrome and other functional abdominal pain disorders: an update of non-pharmacological treatments

, &
Pages 447-456 | Received 12 Jan 2018, Accepted 05 Apr 2018, Published online: 16 Apr 2018

References

  • Robin SG, Keller C, Zwiener R, et al. Prevalence of pediatric functional gastrointestinal disorders utilizing the Rome IV criteria. J Pediatr. 2018 Apr;195:134-139.
  • Dhroove G, Saps M, Garcia-Bueno C, et al. Prevalence of functional gastrointestinal disorders in Mexican schoolchildren. Rev Gastroenterol Mex. 2017;82:13–18.
  • Hyams JS, Di Lorenzo C, Miguel S, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2016;150:1456–1468.
  • Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016 Feb 19;Pii: S0016-5085(16):002237.
  • Rouster AS, Karpinski AC, Silver D, et al. Functional gastrointestinal disorders dominate pediatric gastroenterology outpatient practice. J Pediatr Gastroenterol Nutr. 2016;62(6):847–851.
  • Bahar RJ, Collins BS, Steinmetz B, et al. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152(5):685–689.
  • Kaminski A, Kamper A, Thaler K, et al. Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents. Cochrane Database Syst Rev. 2011 July 6;(7):CD008013.
  • Collins BS, Lin HC. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. J Pediatr Gastroenterol Nutr. 2011;52:382–386.
  • Madani S, Cortes O, Thomas R. Cyproheptadine use in children with functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2016;62(3):409–413.
  • Van Tilburg MA, Palsson OS, Levy RL, et al. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med. 2008;8:46.
  • Reed-Knight B, Squires M, Chitkara DK, et al. Adolescents with irritable bowel syndrome report increased eating-associated symptoms, changes in dietary composition, and altered eating behaviors: a pilot comparison study to healthy adolescents. Neurogastroenterol Motil. 2016;28(12):1915–1920.
  • Carlson MJ, Moore CE, Tsai CM, et al. Child and parent perceived food-induced gastrointestinal symptoms and quality of life in children with functional gastrointestinal disorders. J Acad Nutr Diet. 2014 Mar;114(3):403–413.
  • Khayyatzadeh SS, Kazemi-Bajestani SMR, Mirmousavi SJ, et al. Dietary behaviors in relation to prevalence of irritable bowel syndrome in adolescent girls. J Gastroenterol Hepatol. 2018 Feb;33(2):404–410.
  • Catassi G, Lionetti E, Gatti S, et al. The low FODMAP diet: many question marks for a catchy acronym. Nutrients. 2017 Mar 16;9(3):pii: E292.
  • Chumpitazi BP, Weidler EM, Lu DY, et al. Self-perceived food intolerances are common and associated with clinical severity in childhood irritable bowel syndrome. J Acad Nutr Diet. 2016 Sept;116(9):1458–1464.
  • Newlove-Delgado TV, Martin AE, Abbott RA, et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database Syst Rev. 2017 Mar;23(3):CD010972.
  • Shulman RJ, Hollister EB, Cain K, et al. Psyllium fiber reduces abdominal pain in children with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2017;15(5):712–719.
  • Feldman W, McGrath P, Hodgson C, et al. The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double-blind, randomized, controlled trial. Am J Dis Child. 1985 Dec;139(12):1216–1218.
  • El-Salhy M, Ystad SO, Mazzawi T, et al. Dietary fiber in irritable bowel syndrome (review). Int J Mol Med. 2017 Sept;40(3):607–613.
  • Webster RB, DiPalma JA, Gremse DA. Lactose maldigestion and recurrent abdominal pain in children. Dig Dis Sci. 1995;40(7):1506–1510.
  • Van Tilburg MA, Felix CT. Diet and functional abdominal pain in children and adolescents. J Pediatr Gastroenterol Nutr. 2013;57(2):141–148.
  • Gijsbers CF, Kneepkens CM, Büller HA. Lactose and fructose malabsorption in children with recurrent abdominal pain: results of double-blinded testing. Acta Paediatr. 2012 Sep;101(9):e411–5.
  • Lebenthal E, Rossi TM, Nord KS, et al. Recurrent abdominal pain and lactose absorption in children. Pediatrics. 1981;67(6):828–832.
  • Wald A, Chandra R, Fisher SE, et al. Lactose malabsorption in recurrent abdominal pain of childhood. J Pediatr. 1982;100(1):65–68.
  • Huertas-Ceballos AA, Logan S, Bennett C, et al. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003019.
  • Chumpitazi BP, Cope JL, Hollister EB, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther. 2015 Aug;42(4):418–427.
  • McIntosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2017;66(7):1241–1251.
  • Staudacher Hm 1, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017 Aug;66(8):1517–1527.
  • Catassi G, Lionetti E, Gatti S, et al. The low FODMAP diet: many question marks for a catchy acronym. Nutrients. 2017 Mar 16;9(3):292.
  • Stevens L, Rashid M. Gluten-free and regular foods: a cost comparison. Can J Diet Pract Res. 2008;69(3): 147–150. Fall.
  • Van Gils T, Nijeboer P, IJssennagger CE, et al. Prevalence and characterization of self-reported gluten sensitivity in The Netherlands. Nutrients. 2016;8(11).
  • Shewry PR 1, Sj H. Do we need to worry about eating wheat? Nutr Bull. 2016;41(1):6–13.
  • Lis DM, Stellingwerff T, Shing CM, et al. Exploring the popularity, experiences, and beliefs surrounding gluten-free diets in nonceliac athletes. Int J Sport Nutr Exerc Metab. 2015 Feb;25(1):37–45.
  • Lis D, Stellingwerff T, Kitic CM, et al. No effects of a short-term gluten-free diet on performance in nonceliac athletes. Med Sci Sports Exerc. 2015 Dec;47(12):2563–2570.
  • Catassi C, Elli L, Bonaz B, et al. Diagnosis of non-celiac gluten sensitivity (NCGS): the salerno experts’ criteria. Nutrients. 2015 Jun 18;7(6):4966–4977.
  • Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145(2):320–8.e1-3.
  • Giannetti E, Staiano A. Probiotics for irritable bowel syndrome: clinical data in children. J Pediatr Gastroenterol Nutr. 2016;63(Suppl 1):S25–6.
  • Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Ailment Pharmacol Ther. 2011;33(12):1302–1310.
  • Rutten JM, Koterink JJ, Venmans LM, et al. Nonpharmacologic treatment of functional abdominal pain disorders: a systematic review. Pediatrics. 2015;135(3):522–535. Epub 2015 Feb 9.
  • Wang YM, Ge XZ, Wang WQ, et al. Lactobacillus rhamnosus GG supernatant upregulates serotonin transporter expression in intestinal epithelial cells and mice intestinal tissues. Neurogastroentero Motil. 2015;27(9):1239–1248. Epub 2015 Jun 18.
  • Jadrešin O, Hojsak I, Mišak Z, et al. Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT study. J Pediatr Gastroenterol Nutr. 2017;64(6):925–929.
  • Maragkoudaki M, Chouliaras G, Orel R, et al. Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain. Acta Paediatr. 2017;106(11):1857–1862.
  • Weizman Z, Abu-Abed J, Binsztok M. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2016;174:160–164.
  • Guandalini S, Magazzu G, Chiaro A, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010;51(1):24–30.
  • Giannetti E, Maglione M, Alessandrella A, et al. A mixture of 3 Bifidobacteria decreases abdominal pain and improves quality of life in children with irritable bowel syndrome: a multicenter, randomized, double-blind, placebo-controlled, crossover trial. J Clin Gastroenterol. 2017;51(1):e5–e10.
  • Kline RM, Kline JJ, Di Palma J, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001 Jan;138(1):125–128.
  • Asgarshirazi M, Shariat M, Dalili H. Comparison of the effects of pH-dependent peppermint oil and symbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo-controlled study. Iran Red Crescent Med J. 2015 Apr 25;17(4):e23844.
  • Mahler T. Education and hypnosis for treatment of functional gastrointestinal disorders (FGIDs) in pediatrics. Am J Clin Hypn. 2015;58(1):115–128.
  • Vlieger AM, Menko-Frankenhuis C, Wolfkamp SC, et al. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology. 2007;133(5):1430–1436.
  • Anbar RD. Hypnosis in pediatrics: applications at the pediatric pulmonary center. BMC Pediatr. 2002 Dec 3;2:11. Epub 2002 Dec 3.
  • Olness KN. Hypnotherapy in children. New approach to solving common pediatric problems. Postgrad Med. 1986;79(4):95–100.
  • Vlieger AM, Rutten JM, Govers AM, et al. Long-term follow-up of gut-directed hypnotherapy vs standard care in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol. 2012;107(4):627–631.
  • Rutten JM, Reitsma JB, Vlieger AM, et al. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review. Arch Dis Child. 2013;98(4):252–257.
  • Palsson OS. Hypnosis treatment of gastrointestinal disorders: a comprehensive review of the empirical evidence. Am J Clin Hypn. 2015;58(2):134–158.
  • Rutten JMTM, Vlieger AM, Frankenhuis C, et al. Home-based hypnotherapy self-exercises vs individual hypnotherapy with a therapist for treatment of pediatric irritable bowel syndrome, functional abdominal pain, or functional abdominal pain syndrome: a randomized clinical trial. JAMA Pediatr. 2017;1(5):470–477. 17IBS.
  • Brands MM, Purperhart H, Deckers-Kocken JM. A pilot study of yoga treatment in children with functional abdominal pain and irritable bowel syndrome. Complement Ther Med. 2011;19(3):109–114.
  • Kuttner L, Chambers CT, Hardial J, et al. A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Res Manag. 2006;11(4):217–223.
  • Evans S, Lung KC, Seidman LC, et al. Iyengar yoga for adolescents and young adults with irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2014;59(2):244–253.
  • Schumann D, Anheyer D, Lauche R, et al. Effect of yoga in the therapy of irritable bowel syndrome: a systematic review. Clin Gastroenterol Hepatol. 2016 Dec;14(12):1720–1731.
  • Ballou S, Keefer L. Psychological interventions for irritable bowel syndrome and inflammatory bowel diseases. Clin Transl Gastroenterol. 2017 Jan;8(1):e214.
  • Lalouni M, Ljotsson B, Bonnert M, et al. Internet-delivered cognitive behavioral therapy for children with pain-related functional gastrointestinal disorders: feasibility study. JMIR Ment Health. 2017;4(3):e32.
  • Levy RL, Langer SL, Van Tilburg MA, et al. Brief telephone-delivered cognitive behavioral therapy targeted to parents of children with functional abdominal pain: a randomized controlled trial. Pain. 2017;158(4):618–628.
  • Law EF, Fisher E, Howard WJ, et al. Longitudinal change in parent and child functioning after internet-delivered cognitive behavioral therapy for chronic pain. Pain. 2017;158(10):1992–2000.
  • Toivonen KI, Zernicke K, Carlson LE. Web-based mindfulness interventions for people with physical health conditions: systematic review. Med Internet Res. 2017 Aug 31;19(8):e303.
  • Ljotsson B, Falk L, Vesterlund AW, et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome – a randomized controlled trial. Behav Res Ther. 2010 Jun;48(6):531–539. Epub 2010 Mar 16.
  • Shapiro F. Errors of context and review of eye movement desensitization and reprocessing research. J Behav Ther Exp Psychiatry. 1996 Sept;27(3):313–317.
  • Tefft AJ, Jodan I. Eye movement desensitization reprocessing as treatment for chronic pain syndromes: a literature review. J Am Psychiatr Nurses Assoc. 2016 Apr 5. pii: 1078390316642519.
  • Hoekman DR, Zeevenhooven J, Van Elten-Jamaludin FS, et al. The placebo response in pediatric abdominal pain-related functional gastrointestinal disorders: a systematic review and meta-analysis. J Pediatr. 2017;182:155–163.
  • Saps M, Youssef N, Miranda A, et al. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137(4):1261–1269.
  • Lu CL, Chang FY. Placebo effect in patients with irritable bowel syndrome. J Gastroenterol Hepatol. 2011;26(Suppl 3):116–118.
  • Kaptchuk TJ, Friedlander R, Kelley JM, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010;5(12):e15591.
  • Dorn SD, Kaptchuk TJ, Park JB, et al. A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterol Motil. 2007;19(8):630–637.
  • Charlesworth JEG, Petkovic G, Kelley JM, et al. Effects of placebos without deception compared with no treatment: A systematic review and meta-analysis. J Evid Based Med. 2017;10(2):97–107.
  • Faria V, Kossowsky J, Petkov MP, et al. Parental attitudes about placebo use in children. J Pediatr. 2017;181:272–278.
  • Babygirija R, Sood M, Kannampalli P, et al. Percutaneous electrical nerve field stimulation modulates central pain pathways and attenuates post-inflammatory visceral and somatic hyperalgesia in rats. Neuroscience. 2017;356:11–21.
  • Kovacic K, Hainsworth K, Sood M, et al. Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trial. Lancet Gastroenterol Hepatol. 2017;2(10):727–737.
  • Algladi T, Harris M, Whorwell PJ, et al. Modulation of human visceral sensitivity by noninvasive magnetoelectrical neural stimulation in health and irritable bowel syndrome. Pain. 2015;156(7):1348–1356.
  • Wojtowicz AA, Banez GA. Adolescents with chronic pain and associated functional disability: A descriptive analysis. J Child Health Care. 2015 Dec;19(4):478–484. . Epub 2014 Mar 18.
  • Stern MJ, Guiles RA, Gevirtz R. HRV biofeedback for pediatric irritable bowel syndrome and functional abdominal pain: a clinical replication series. Appl Psychophysiol Biofeedback. 2014 Dec;39(3–4):287–291.
  • Buckle J. Use of aromatherapy as a complementary treatment for chronic pain. Altern Ther Health Med. 1999 Sep;5(5):42–51.
  • Kiberd MB, Clarke SK, Chorney J, et al. Aromatherapy for the treatment of PONV in children: a pilot RCT. BMC Complement Altern Med. 2016 Nov 9;16(1):450.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.